Last edition
News about "Lupin Pharmaceuticals"
Lupin Announces Approval from US FDA for Pitolisant Tablets
Lupin receives US Food and Drug Administration (FDA) approval for Pitolisant Tablets, 4.45 mg and 17.8 mg, a generic version of Wakix, for indications covered by the approved labeling.
Lupin Pharmaceuticals | 17/08/2026 | By News Bureau
Lupin Secures US Approval for Sodium Zirconium Cyclosilicate Oral Suspension
Lupin has received US Food and Drug Administration (FDA) approval for Sodium Zirconium Cyclosilicate Oral Suspension, 5 g and 10 g, bioequivalent to AstraZeneca’s Lokelma.
Lupin Pharmaceuticals | 11/08/2026 | By News Bureau
Lupin Launches Azilsartan Medoxomil Tablets in US
Lupin has launched Azilsartan Medoxomil Tablets in the US, a bioequivalent generic version of Edarbi, indicated for the treatment of hypertension in adults.
Lupin Pharmaceuticals | 17/06/2026 | By News Bureau | 117
US FDA Completes Pre-Approval Inspection at Lupin's Somerset Facility with One Observation
The US Food and Drug Administration (FDA) has completed a pre-approval inspection of Lupin’s manufacturing facility in Somerset, New Jersey, USA, with one observation.
Lupin Pharmaceuticals | 11/10/2025 | By Dineshwori | 584
Lupin Pharmaceuticals | 23/01/2023 | By Sudeep Soparkar | 1362
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy